Clinical Research Doctors Medicine Pharma Companies 
pharmaphorum
JANUARY 24, 2022
The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 million in funding from French drugmaker Sanofi.
XTalks
DECEMBER 20, 2023
Check out this article to learn about the biotech companies that went public this year. The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 21, 2021
Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA.
Pharmaceutical Technology
MARCH 17, 2023
This is partly due to the differing business models used by pharma companies and digital therapeutic developers. In the future , digital therapeutics could serve as a complementary option that makes patients’ lives easier, says Dr. Jochen Klucken, chair of digital medicine at the University of Luxembourg.
pharmaphorum
SEPTEMBER 1, 2020
Similarly, whilst GlaxoSmithKline’s origins can be traced back as far as 1715, it was only in the middle of the 19th century that Beecham became involved in the industrial production of medicine, producing patented medicine from 1842, and the world’s first factory for producing only medicines in 1859.
pharmaphorum
MARCH 12, 2021
That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s Clinical Research Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. Thankfully, many pharma companies seem to be gradually improving on this. Listening to patients.
Cloudbyz
SEPTEMBER 25, 2020
Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. Time spent on clinical trials involves investment and being able to predict ADRs assists with improving the success rate. What About The Other 159 Solutions?
Expert insights. Personalized for you.
97 
Let's personalize your content